The team lead by Sílvia Vilares Conde, from CEDOC-NOVA Medical School, in collaboration with the pharmaceutical company Galvani Bioelectronics, demonstrated through findings in rats that is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain.
The study is published in Diabetologia, the journal of the European Association for the Study of Diabetes [EASD].
In 2013, Silvia Vilares Conde and her research group described that the carotid body, a paired organ that is located in the bifurcation of the common carotid artery and that is classically defined as an oxygen sensor, regulates peripheral insulin sensitivity and that its dysfunction is involved in the development of metabolic diseases.
This first study and others afterwards performed by her group in diabetic rats showed that the bilateral resection of the carotid sinus nerve, and therefore the abolishment of the connection between the carotid body and the brain, restore insulin sensitivity and glucose tolerance. Although efficient this surgical irreversible approach has disadvantages, since the carotid body possess other physiological functions as the response to the lack of oxygen (hypoxia) or the adaptation to exercise. Silvia Conde’s team also described that the carotid body is over-activated in animal models of type 2 diabetes, suggesting that decreasing the activity of the organ could be a good therapeutic strategy.
From the partnership with Galvani Bioelectronics (former Glaxo Smith Kline Bioelectronics), the opportunity to electrically modulate the carotid sinus nerve come up. In fact, this work demonstrated that is possible to maintain glucose homeostasis in animals in which electrodes have been implanted in the carotid sinus nerve and submitted to electrical modulation, without significant adverse effects. It has also been demonstrated that the electrical modulation is reversible. Silvia Conde notes that “this work opens the door to the development of a new therapeutic for type 2 diabetes that will provide a long-term management of the disease with negligible adverse effects and interference with daily activities”.
Type 2 diabetes is characterized by insulin resistance and by increased hepatic glucose production that culminates in hyperglycemia. Although a lot of efforts have been performed until the date none therapeutic induce long-term glycaemia control, being expected for the next decades a huge increase in the prevalence of the disease. Thus, this work gives hope to patients with metabolic diseases, as it brings a new approach for the management of type 2 diabetes.
The Latest on: Type 2 diabetes
- Smart Meter's iGlucose Cellular Diabetes Care Solution Demonstrated to Help High Risk Patients on February 19, 2019 at 9:40 am
... United States and other countries have shown that controlling blood glucose benefits people with either type 1 or type 2 diabetes. Overall, for every 1.0-point reduction in A1C, the risk of develo... […]
- Researcher gets $552,000 grant to study how dietary fiber can protect against diabetes on February 19, 2019 at 8:40 am
This knowledge could enable harnessing of these pathways to safely treat and prevent type 2 diabetes. "In this work, we expect to develop new strategies to maintain a healthy intestinal-microbiota rel... […]
- Deintensifying Diabetes Drugs: Important Considerations on February 19, 2019 at 8:10 am
We hear a lot about the importance of intensifying insulin therapy in our patients with type 2 diabetes. And that is reasonable; it is important to get people to goal. A corollary that is becoming ver... […]
- Higher heart rates related to type 2 diabetes risk in normal-weight adults on February 19, 2019 at 8:01 am
The risk for developing type 2 diabetes is higher for Chinese adults with increased heart rates, even those in the high normal range, compared with those with lower rates, especially in combination wi... […]
- Bright sunlight exposure may decrease risk for type 2 diabetes, CVD on February 19, 2019 at 7:18 am
“Spending more time outdoors in the sun might be associated with health benefits,” Constantinos Christodoulides, MD, PhD, a university research lecturer and honorary consultant in diabetes and endocri... […]
- I've Been Diagnosed With Gestational Diabetes. Now What? on February 19, 2019 at 7:12 am
However, if it’s especially high – 200 or more, you may have Type 2 diabetes, NIDDK notes. And if your reading is above 190, you may be diagnosed with gestational diabetes without undergoing ... […]
- Diabetes still a dangerous condition in era of modern medicine on February 19, 2019 at 6:51 am
According to a recent Harris Poll, only about half of people 45 and older with Type 2 diabetes recognized their risk for a heart attack or stroke. About 26 million American adults have been diagnosed ... […]
- Oestrogen and controlling Type 2 diabetes on February 17, 2019 at 1:25 am
The results of a recent Texas A&M University-led study provide insights into the mechanism by which oestrogen can decrease insulin resistance and the production of glucose, reducing incidence of ... […]
- How Does Weight Fluctuation Affect Type 2 Diabetes? on February 15, 2019 at 4:17 pm
Major changes in weight, including weight loss, can affect diagnosis risk. In type 2 diabetes, it is important to counsel patients on managing their body weight due to evidence of the negative impact ... […]
- What No One Told Me About Accepting a Type 2 Diabetes Diagnosis on February 14, 2019 at 11:17 am
When I was diagnosed with type 2 diabetes in 2011, I had a hard time processing it. I spent weeks, if not months, wondering how this happened to me and if I was diagnosed correctly this time. Initiall... […]
via Google News and Bing News